Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Application of Sodium Valproate Personalized Medication Based on Pharmacogenetics

NCT07046676 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of South China as lead sponsor.

NCT NCT07046676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07046676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Application of Sodium Valproate Personalized Medication Based on Pharmacogenetics
Lead sponsor
The First Affiliated Hospital of University of South China
Phase
Phase 4
Overall status
Recruiting
Start date
December 1, 2022
Completion date
May 30, 2026
Enrollment
312 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy